Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC240903 Ex Vivo Expansion of Tumor Antigen-Specific T Cells for Adoptive T Cell Therapy

NCT07137312 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07137312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07137312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC240903 Ex Vivo Expansion of Tumor Antigen-Specific T Cells for Adoptive T Cell Therapy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
December 16, 2025
Completion date
October 31, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, malignant solid neoplasm, solid tumor